This prospective multicenter observational study compared plasma cell-free mitochondrial DNA (cf-mtDNA) kinetics in matched adult lung transplant recipients from controlled donation after circulatory determination of death (cDCD) vs. donors after brain death (DBD), evaluating whether cf-mtDNA levels reflect donor warm ischemic injury.
Donor plasma cf-mtDNA levels were similar between cDCD and DBD groups; a donor type-by-time interaction emerged at 72 hours post-transplant, but neither total nor functional warm ischemia time was independently associated with cf-mtDNA concentrations. Exploratory data showed graft-derived mtDNA declined from reperfusion to 72 hours even as total cf-mtDNA rose, suggesting recipient-driven inflammation rather than donor warm ischemia drives post-transplant systemic cf-mtDNA dynamics.
Observational design limits causal inference; exploratory donor-derived cf-mtDNA analysis was hypothesis-generating only; the matched cohort may not fully represent all cDCD lung transplant scenarios.
Systemic cf-mtDNA should not be used as a surrogate marker for donor warm ischemic injury after cDCD lung transplantation. Clinicians interpreting elevated post-transplant cf-mtDNA levels should consider recipient inflammatory responses as the primary driver.
Explore related topics